{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:28:55Z","timestamp":1790278135734,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bbr.2025.115692","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T19:12:26Z","timestamp":1749582746000},"page":"115692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Neuroprotective effects of quercetin on motor impairments and anxiety-like behaviors in a rat model of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"493","author":[{"given":"Maryam","family":"Yousefi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Mirshekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Afsharfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeideh","family":"Arabmoazzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Haghparast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2025.115692_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.54254\/2753-8818\/47\/2024PJ0101","article-title":"The pathogenesis and treatment of Parkinson's disease","volume":"47","author":"Tong","year":"2024","journal-title":"Theor. Nat. Sci."},{"key":"10.1016\/j.bbr.2025.115692_bib2","doi-asserted-by":"crossref","unstructured":"Korenblum S., Korczyn A.D., Gurevich T. Parkinson's disease. 2024.","DOI":"10.1016\/B978-0-323-99967-0.00172-1"},{"issue":"1","key":"10.1016\/j.bbr.2025.115692_bib3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41531-024-00781-4","article-title":"Alpha-synuclein-induced nigrostriatal degeneration and pramipexole treatment disrupt frontostriatal plasticity","volume":"10","author":"Chevalier","year":"2024","journal-title":"npj Park. 'S. Dis."},{"key":"10.1016\/j.bbr.2025.115692_bib4","doi-asserted-by":"crossref","unstructured":"Maffitt N.J., Banerjee S., Sarkar S., Majumdar S., Choudhury S., Kumar H., et al. A novel method to assess motor planning deficits in patients with Parkinson's disease and mild cognitive impairment. medRxiv. 2024:2024.11. 19.24317500.","DOI":"10.1101\/2024.11.19.24317500"},{"issue":"1","key":"10.1016\/j.bbr.2025.115692_bib5","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1038\/s41598-023-31299-z","article-title":"Robot-assisted investigation of sensorimotor control in Parkinson's disease","volume":"13","author":"Tamilselvam","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbr.2025.115692_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2023.103541","article-title":"Motor networks, but also non-motor networks predict motor signs in Parkinson\u2019s disease","volume":"40","author":"Ragothaman","year":"2023","journal-title":"NeuroImage Clin."},{"issue":"904","key":"10.1016\/j.bbr.2025.115692_bib7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/pmj.77.904.89","article-title":"Parkinson\u2019s disease and anxiety","volume":"77","author":"Walsh","year":"2001","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.bbr.2025.115692_bib8","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00415-011-6392-3","article-title":"Gender-related differences in the burden of non-motor symptoms in Parkinson\u2019s disease","volume":"259","author":"Martinez-Martin","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbr.2025.115692_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/ejn.16577","article-title":"Dopamine loss alters glutamate synapses and transporters in the medial prefrontal cortex and anxiety-related behaviour in a male MPTP rodent model of Parkinson's disease","author":"Moore","year":"2024","journal-title":"Eur. J. Neurosci."},{"issue":"5","key":"10.1016\/j.bbr.2025.115692_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/JNN.0000000000000770","article-title":"Anxiety Symptoms and Disease Severity in Parkinson Disease","volume":"56","author":"Whitmarsh","year":"2024","journal-title":"J. Neurosci. Nurs."},{"issue":"1","key":"10.1016\/j.bbr.2025.115692_bib11","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1186\/s12888-024-05972-0","article-title":"Stress perception and associated factors among patients with Parkinson\u2019s disease: a cross-sectional study after the COVID-19 pandemic","volume":"24","author":"Pan","year":"2024","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.bbr.2025.115692_bib12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s12877-024-04854-0","article-title":"Parkinson\u2019s disease with anxiety: clinical characteristics and their correlation with oxidative stress, inflammation, and pathological proteins","volume":"24","author":"Lian","year":"2024","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.bbr.2025.115692_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.12703\/b\/9-6","article-title":"Recent advances in understanding and treatment of Parkinson\u2019s disease","volume":"9","author":"Tarakad","year":"2020","journal-title":"Fac. Rev."},{"key":"10.1016\/j.bbr.2025.115692_bib14","doi-asserted-by":"crossref","unstructured":"Pons-Espinal M., Blasco-Agell L., Fernandez-Carasa I., di Domenico A., Richaud Y., Mosquera J.L., et al. Immunosuppressive tocilizumab prevents astrocyte induced neurotoxicity in hiPSC-LRRK2 Parkinson\u2019s disease by targeting receptor interleukin-6. bioRxiv. 2022:2022.08. 23.504918.","DOI":"10.1101\/2022.08.23.504918"},{"key":"10.1016\/j.bbr.2025.115692_bib15","doi-asserted-by":"crossref","unstructured":"Shafi V. Lewy Body Formation through the lens of Cytokine-Mediated Neuroinflammation in Parkinson's Disease Development. 2024.","DOI":"10.21203\/rs.3.rs-4232044\/v1"},{"issue":"4","key":"10.1016\/j.bbr.2025.115692_bib16","first-page":"454","article-title":"Neuroinflammation and immune dysfunction in the pathogenesis of Parkinson\u2019s disease","volume":"73","author":"Idova","year":"2023","journal-title":"Zh Vyss. Nervn. Deyatelnosti Im. IP Pavlov."},{"issue":"3","key":"10.1016\/j.bbr.2025.115692_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163359","article-title":"Blocking IL-6 signaling prevents astrocyte-induced neurodegeneration in an iPSC-based model of Parkinson\u2019s disease","volume":"9","author":"Pons-Espinal","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbr.2025.115692_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.nutres.2023.10.004","article-title":"Dietary flavonoids may have a protective and therapeutic effect in Parkinson disease: a systematic review","volume":"121","author":"Gonz\u00e1lez-May","year":"2023","journal-title":"Nutr. Res. (N. Y. NY)"},{"issue":"2","key":"10.1016\/j.bbr.2025.115692_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neulet.2011.06.021","article-title":"Neuroprotective effect of bioflavonoid quercetin in 6-hydroxydopamine-induced oxidative stress biomarkers in the rat striatum","volume":"500","author":"Haleagrahara","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"7","key":"10.1016\/j.bbr.2025.115692_bib20","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.freeradbiomed.2011.06.017","article-title":"Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats","volume":"51","author":"Ishisaka","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.bbr.2025.115692_bib21","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/jnc.14033","article-title":"Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson's Disease","volume":"141","author":"Ay","year":"2017","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.bbr.2025.115692_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258928","article-title":"Quercetin exhibits potent antioxidant activity, restores motor and non-motor deficits induced by rotenone toxicity","volume":"16","author":"Madiha","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbr.2025.115692_bib23","article-title":"Effect of Quercetin in the 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-Induced Mouse Model of Parkinson\u2032 s Disease","volume":"2012","author":"Lv","year":"2012","journal-title":"Evid. -Based Complement. Altern. Med."},{"issue":"17","key":"10.1016\/j.bbr.2025.115692_bib24","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.2174\/0115701808294683240531111346","article-title":"Isoquercetin neuroprotective molecular targets in Parkinson\u2019s disease: recent highlights and future perspectives","volume":"21","author":"Kaur","year":"2024","journal-title":"Lett. Drug Des. Discov."},{"issue":"1","key":"10.1016\/j.bbr.2025.115692_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4892415","article-title":"Protective effects of quercetin on anxiety-like symptoms and neuroinflammation induced by lipopolysaccharide in rats","volume":"2020","author":"Lee","year":"2020","journal-title":"Evid. -Based Complement. Altern. Med."},{"key":"10.1016\/j.bbr.2025.115692_bib26","first-page":"1","article-title":"In silico and in vivo studies on quercetin as potential anti-Parkinson agent","author":"Boyina","year":"2020","journal-title":"GeNeDis 2018 Genetics Neurodegeneration"},{"issue":"1","key":"10.1016\/j.bbr.2025.115692_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bcpt.14011","article-title":"Effects of quercetin in preclinical models of Parkinson's disease: A systematic review","volume":"135","author":"de Oliveira Vian","year":"2024","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"5","key":"10.1016\/j.bbr.2025.115692_bib28","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2174\/1389450120666191112155654","article-title":"The therapeutic potential of quercetin in Parkinson\u2019s disease: insights into its molecular and cellular regulation","volume":"21","author":"Tamtaji","year":"2020","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bbr.2025.115692_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-8-14","article-title":"Behavioral characterization of the 6-hydroxidopamine model of Parkinson\u2019s disease and pharmacological rescuing of non-motor deficits","volume":"8","author":"Carvalho","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbr.2025.115692_bib30","series-title":"The rat brain in stereotaxic coordinates: hard cover edition","author":"Paxinos","year":"2006"},{"issue":"6","key":"10.1016\/j.bbr.2025.115692_bib31","first-page":"599","article-title":"Effects of quercetin on spatial memory, hippocampal antioxidant defense and BDNF concentration in a rat model of Parkinson\u2019s disease: An electrophysiological study","volume":"11","author":"Naghizadeh","year":"2021","journal-title":"Avicenna J. Phytomedicine"},{"issue":"1","key":"10.1016\/j.bbr.2025.115692_bib32","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/cercor\/bhab201","article-title":"Low-intensity pulsed ultrasound enhances neurotrophic factors and alleviates neuroinflammation in a rat model of Parkinson\u2019s disease","volume":"32","author":"Sung","year":"2022","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.bbr.2025.115692_bib33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-4939-8994-2_9","article-title":"The open field test for measuring locomotor activity and anxiety-like behavior","author":"Kraeuter","year":"2019","journal-title":"PreClin. Model. Tech. Protoc."},{"issue":"3","key":"10.1016\/j.bbr.2025.115692_bib34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ntt.2012.02.003","article-title":"Neurobehavioral assessment of mice following repeated postnatal exposure to chlorpyrifos-oxon","volume":"34","author":"Cole","year":"2012","journal-title":"Neurotoxicology Teratol."},{"issue":"1","key":"10.1016\/j.bbr.2025.115692_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-19713-4","article-title":"The prevention of home-cage grid climbing affects muscle strength in mice","volume":"12","author":"Ueno","year":"2022","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bbr.2025.115692_bib36","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/10253890.2018.1438405","article-title":"Exploratory rearing: a context-and stress-sensitive behavior recorded in the open-field test","volume":"21","author":"Sturman","year":"2018","journal-title":"Stress"},{"key":"10.1016\/j.bbr.2025.115692_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.111981","article-title":"Anxiety-like behavior induced by 6-OHDA animal model of Parkinson\u2019s disease may be related to a dysregulation of neurotransmitter systems in brain areas related to anxiety","volume":"371","author":"Vieira","year":"2019","journal-title":"Behav. brain Res."},{"key":"10.1016\/j.bbr.2025.115692_bib38","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.physbeh.2014.11.045","article-title":"Chronic psychological stress in high-anxiety rats induces sustained bladder hyperalgesia","volume":"139","author":"Lee","year":"2015","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbr.2025.115692_bib39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuint.2018.11.005","article-title":"Behavioral tests predicting striatal dopamine level in a rat hemi-Parkinson's disease model","volume":"122","author":"Miyanishi","year":"2019","journal-title":"Neurochem. Int."},{"issue":"2","key":"10.1016\/j.bbr.2025.115692_bib40","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nprot.2007.44","article-title":"The use of the elevated plus maze as an assay of anxiety-related behavior in rodents","volume":"2","author":"Walf","year":"2007","journal-title":"Nat. Protoc."},{"issue":"8","key":"10.1016\/j.bbr.2025.115692_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e18401","article-title":"Continuous intake of quercetin-rich onion powder may improve emotion but not regional cerebral blood flow in subjects with cognitive impairment","volume":"9","author":"Hayashi","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.bbr.2025.115692_bib42","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00210-014-1008-y","article-title":"Quercetin mitigates Adriamycin-induced anxiety-and depression-like behaviors, immune dysfunction, and brain oxidative stress in rats","volume":"387","author":"Merzoug","year":"2014","journal-title":"NaunynSchmiede 'S. Arch. Pharmacol."},{"issue":"8","key":"10.1016\/j.bbr.2025.115692_bib43","doi-asserted-by":"crossref","first-page":"11738","DOI":"10.18632\/aging.202868","article-title":"Administration of quercetin improves mitochondria quality control and protects the neurons in 6-OHDA-lesioned Parkinson's disease models","volume":"13","author":"Wang","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.bbr.2025.115692_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7769355","article-title":"Quercetin Protects against MPP+\/MPTP-Induced Dopaminergic Neuron Death in Parkinson\u2019s Disease by Inhibiting Ferroptosis","volume":"2022","author":"Lin","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.bbr.2025.115692_bib45","first-page":"53","article-title":"Isolongifolene attenuates oxidative stress and behavioral impairment in rotenone-induced rat model of Parkinson\u2019s disease","volume":"8","author":"Balakrishnan","year":"2018","journal-title":"Int. J. Nutr. Pharmacol. Neurol. Dis."},{"issue":"11","key":"10.1016\/j.bbr.2025.115692_bib46","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1080\/00207454.2022.2074848","article-title":"Hydroxychloroquine attenuated motor impairment and oxidative stress in a rat 6-hydroxydopamine model of Parkinson\u2019s disease","volume":"133","author":"Athari","year":"2023","journal-title":"Int. J. Neurosci."},{"issue":"7","key":"10.1016\/j.bbr.2025.115692_bib47","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/jbt.21821","article-title":"Ameliorative effect of quercetin on neurochemical and behavioral deficits in rotenone rat model of Parkinson's disease: modulating autophagy (quercetin on experimental Parkinson's disease)","volume":"30","author":"El-Horany","year":"2016","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bbr.2025.115692_bib48","article-title":"Quercetin mitigates methamphetamine-induced anxiety-like behavior through ameliorating mitochondrial dysfunction and neuroinflammation","volume":"15","author":"Chen","year":"2022","journal-title":"Front. Mol. Neurosci."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432825002797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432825002797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T06:12:30Z","timestamp":1755497550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432825002797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":48,"alternative-id":["S0166432825002797"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2025.115692","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective effects of quercetin on motor impairments and anxiety-like behaviors in a rat model of Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2025.115692","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115692"}}